{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:13:28Z","timestamp":1789053208283,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KFO 218"],"award-info":[{"award-number":["KFO 218"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr. Diabetes"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background\/objectives<\/jats:title>\n                <jats:p>Numerous hepatokines are involved in inter-organ cross talk regulating tissue-specific insulin sensitivity. Adipose tissue lipolysis represents a crucial element of adipose insulin sensitivity and is substantially involved in long-term body weight regulation after dietary weight loss. Thus, we aimed to analyze the impact of the hepatokine Fetuin-B in the context of weight loss induced short- and long-term modulation of adipose insulin sensitivity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Subjects\/methods<\/jats:title>\n                <jats:p>143 subjects (age\u2009&gt;\u200918; BMI\u2009\u2265\u200927\u2009kg\/m<jats:sup>2<\/jats:sup>) were analyzed before (T-3) and after (T0) a standardized 12-week dietary weight reduction program. Afterward, subjects were randomized to a 12-month lifestyle intervention or a control group. After 12 months (T12) no further intervention was performed until 6 months later (T18) (Maintain-Adults trial). Tissue-specific insulin sensitivity was estimated by HOMA-IR (predominantly liver), ISI<jats:sub>Clamp<\/jats:sub> (predominantly skeletal muscle), and free fatty acid suppression during hyperinsulinemic-euglycemic clamp (FFA<jats:sub>Supp<\/jats:sub>) (predominantly adipose tissue). Fetuin-B was measured at all concomitant time points.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Circulating Fetuin-B levels correlated significantly with estimates of obesity, hepatic steatosis as well as HOMA-IR, ISI<jats:sub>Clamp<\/jats:sub>, FFA<jats:sub>Supp<\/jats:sub> at baseline. Fetuin-B decreased during dietary weight loss (4.2 (3.5\u20134.9) vs. 3.8 (3.2\u20134.6)\u2009\u00b5g\/ml; <jats:italic>p<\/jats:italic>\u2009=\u20092.1\u2009\u00d7\u200910<jats:sup>\u22125<\/jats:sup>). This change was associated with concomitant improvement of HOMA-IR (<jats:italic>r<\/jats:italic>\u2009=\u20090.222; <jats:italic>p<\/jats:italic>\u2009=\u20090.008) and FFA<jats:sub>Supp<\/jats:sub> (<jats:italic>r<\/jats:italic>\u2009=\u2009\u22120.210; <jats:italic>p<\/jats:italic>\u2009=\u20090.013), suggesting a particular relationship to hepatic and adipose tissue insulin sensitivity. Weight loss induced improvements of insulin resistance were almost completely preserved until months 12 and 18 and most interestingly, the short and long-term improvement of FFA<jats:sub>Supp<\/jats:sub> was partially predicted by baseline level of Fetuin-B.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our data suggest that Fetuin-B might be a potential mediator of liver-adipose cross talk involved in short- and long-term regulation of adipose insulin sensitivity, especially in the context of diet-induced weight changes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov number: NCT00850629, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00850629\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00850629<\/jats:ext-link>, date of registration: February 25, 2009.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41387-021-00174-z","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T15:59:26Z","timestamp":1633449566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Fetuin-B, a potential link of liver-adipose tissue cross talk during diet-induced weight loss\u2013weight maintenance"],"prefix":"10.1038","volume":"11","author":[{"given":"Linna","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Spranger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Stob\u00e4us","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finja","family":"Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Decker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Wernicke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6336-3939","authenticated-orcid":false,"given":"Sebastian","family":"Brachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Brachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Spranger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0126-3155","authenticated-orcid":false,"given":"Knut","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,5]]},"reference":[{"key":"174_CR1","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/oby.21454","volume":"24","author":"JW Coughlin","year":"2016","unstructured":"Coughlin JW, Brantley PJ, Champagne CM, Vollmer WM, Stevens VJ, Funk K, et al. The impact of continued intervention on weight: five-year results from the weight loss maintenance trial. Obesity 2016;24:1046\u201353.","journal-title":"Obesity"},{"key":"174_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/651460","volume":"2015","author":"T Pekkarinen","year":"2015","unstructured":"Pekkarinen T, Kaukua J, Mustajoki P. Long-term weight maintenance after a 17-week weight loss intervention with or without a one-year maintenance program: a randomized controlled trial. J Obes. 2015;2015:1\u201310.","journal-title":"J Obes"},{"key":"174_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2337\/db18-0440","volume":"68","author":"K Mai","year":"2019","unstructured":"Mai K, Li L, Wiegand S, Brachs M, Leupelt V, Ernert A, et al. An integrated understanding of the molecular mechanisms of how adipose tissue metabolism affects long-term body weight maintenance. Diabetes 2019;68:57\u201365.","journal-title":"Diabetes"},{"key":"174_CR4","doi-asserted-by":"crossref","unstructured":"Oh KJ, Lee DS, Kim WK, Han BS, Lee SC, Bae KH. Metabolic adaptation in obesity and type II diabetes: myokines, adipokines and hepatokines. Int J Mol Sci. 2016;18:8.","DOI":"10.3390\/ijms18010008"},{"key":"174_CR5","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrendo.2017.56","volume":"13","author":"RCR Meex","year":"2017","unstructured":"Meex RCR, Watt MJ. Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance. Nat Rev Endocrinol. 2017;13:509\u201320.","journal-title":"Nat Rev Endocrinol"},{"key":"174_CR6","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/0092-8674(89)90098-6","volume":"58","author":"P Auberger","year":"1989","unstructured":"Auberger P, Falquerho L, Contreres JO, Pages G, Le Cam G, Rossi B, et al. Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell 1989;58:631\u201340.","journal-title":"Cell"},{"key":"174_CR7","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2337\/diacare.29.04.06.dc05-1938","volume":"29","author":"N Stefan","year":"2006","unstructured":"Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Kr\u00f6ber SM, et al. Alpha2-Heremans-Schmid glycoprotein\/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care. 2006;29:853\u20137.","journal-title":"Diabetes Care"},{"key":"174_CR8","doi-asserted-by":"publisher","first-page":"e19228","DOI":"10.1371\/journal.pone.0019228","volume":"6","author":"A Song","year":"2011","unstructured":"Song A, Xu M, Bi Y, Xu Y, Huang Y, Li M, et al. Serum fetuin-A associates with type 2 diabetes and insulin resistance in Chinese adults. PloS one. 2011;6:e19228.","journal-title":"PloS one"},{"key":"174_CR9","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/nm.2851","volume":"18","author":"D Pal","year":"2012","unstructured":"Pal D, Dasgupta S, Kundu R, Maitra S, Das G, Mukhopadhyay S, et al. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med. 2012;18:1279\u201385.","journal-title":"Nat Med"},{"key":"174_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1042\/bj20030676","volume":"376","author":"B Denecke","year":"2003","unstructured":"Denecke B, Gr\u00e4ber S, Sch\u00e4fer C, Heiss A, W\u00f6ltje M, Jahnen-Dechent W. Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A. Biochem J. 2003;376:135\u201345. Pt 1","journal-title":"Biochem J"},{"key":"174_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1042\/CS20140462","volume":"129","author":"SH Jung","year":"2015","unstructured":"Jung SH, Won KJ, Lee KP, Kim HJ, Seo EH, Lee HM, et al. The serum protein fetuin-B is involved in the development of acute myocardial infarction. Clin Sci. 2015;129:27\u201338.","journal-title":"Clin Sci"},{"key":"174_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12020-017-1387-1","volume":"58","author":"K Zhu","year":"2017","unstructured":"Zhu K, Wang Y, Shu P, Zhou Q, Zhu J, Zhou W, et al. Increased serum levels of fetuin B in patients with coronary artery disease. Endocrine 2017;58:97\u2013105.","journal-title":"Endocrine"},{"key":"174_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cyto.2018.03.023","volume":"108","author":"Z Li","year":"2018","unstructured":"Li Z, Lin M, Liu C, Wang D, Shi X, Chen Z, et al. Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: association and path analyses. Cytokine 2018;108:145\u201350.","journal-title":"Cytokine"},{"key":"174_CR14","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.diabet.2018.02.003","volume":"44","author":"H Qu","year":"2018","unstructured":"Qu H, Qiu Y, Wang Y, Liao Y, Zheng Y, Zheng H. Plasma fetuin-B concentrations are associated with insulin resistance and first-phase glucose-stimulated insulin secretion in individuals with different degrees of glucose tolerance. Diabetes Metab. 2018;44:488\u201392.","journal-title":"Diabetes Metab"},{"key":"174_CR15","doi-asserted-by":"publisher","first-page":"E266","DOI":"10.1152\/ajpendo.00262.2017","volume":"314","author":"A Peter","year":"2018","unstructured":"Peter A, Kovarova M, Staiger H, Machann J, Schick F, K\u00f6nigsrainer A, et al. The hepatokines fetuin-A and fetuin-B are upregulated in the state of hepatic steatosis and may differently impact on glucose homeostasis in humans. Am J Physiol Endocrinol Metab. 2018;314:E266\u2013E73.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"174_CR16","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s12020-016-1112-5","volume":"56","author":"J Zhu","year":"2017","unstructured":"Zhu J, Wan X, Wang Y, Zhu K, Li C, Yu C, et al. Serum fetuin B level increased in subjects of nonalcoholic fatty liver disease: a case-control study. Endocrine 2017;56:208\u201311.","journal-title":"Endocrine"},{"key":"174_CR17","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.cmet.2015.09.023","volume":"22","author":"RC Meex","year":"2015","unstructured":"Meex RC, Hoy AJ, Morris A, Brown RD, Lo JC, Burke M, et al. Fetuin B is a secreted hepatocyte factor linking steatosis to impaired glucose metabolism. Cell Metab. 2015;22:1078\u201389.","journal-title":"Cell Metab"},{"key":"174_CR18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/1753-0407.12632","volume":"10","author":"D Wang","year":"2018","unstructured":"Wang D, Liu Y, Liu S, Lin L, Liu C, Shi X, et al. Serum fetuin-B is positively associated with intrahepatic triglyceride content and increases the risk of insulin resistance in obese Chinese adults: a cross-sectional study. J Diabetes. 2018;10:581\u20138.","journal-title":"J Diabetes"},{"key":"174_CR19","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1210\/jc.2018-02378","volume":"104","author":"I Telgenkamp","year":"2019","unstructured":"Telgenkamp I, Kusters Y, Schalkwijk CG, Houben A, Kooi ME, Lindeboom L, et al. Contribution of liver fat to weight loss-induced changes in serum hepatokines: a randomized-controlled trial. J Clin Endocrinol Metab. 2019;104:2719\u201327.","journal-title":"J Clin Endocrinol Metab"},{"key":"174_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1159\/000339065","volume":"30","author":"JW Choi","year":"2012","unstructured":"Choi JW, Liu H, Mukherjee R, Yun JW. Downregulation of fetuin-B and zinc-alpha2-glycoprotein is linked to impaired fatty acid metabolism in liver cells. Cell Physiol Biochem. 2012;30:295\u2013306.","journal-title":"Cell Physiol Biochem"},{"key":"174_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/ijo.2017.199","volume":"42","author":"RI Versteeg","year":"2018","unstructured":"Versteeg RI, Ackermans MT, Nederveen AJ, Fliers E, Serlie MJ, la Fleur SE. Meal timing effects on insulin sensitivity and intrahepatic triglycerides during weight loss. Int J Obes. 2018;42:156\u201362.","journal-title":"Int J Obes"},{"key":"174_CR22","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.cmet.2016.02.005","volume":"23","author":"F Magkos","year":"2016","unstructured":"Magkos F, Fraterrigo G, Yoshino J, Luecking C, Kirbach K, Kelly SC, et al. Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity. Cell Metab. 2016;23:591\u2013601.","journal-title":"Cell Metab"},{"key":"174_CR23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.metabol.2018.01.003","volume":"83","author":"K Mai","year":"2018","unstructured":"Mai K, Brachs M, Leupelt V, Jumpertz-von Schwartzenberg R, Maurer L, Gr\u00fcters-Kieslich A, et al. Effects of a combined dietary, exercise and behavioral intervention and sympathetic system on body weight maintenance after intended weight loss: results of a randomized controlled trial. Metabolism 2018;83:60\u20137.","journal-title":"Metabolism"},{"key":"174_CR24","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.metabol.2016.03.013","volume":"65","author":"M Brachs","year":"2016","unstructured":"Brachs M, Wiegand S, Leupelt V, Ernert A, Kintscher U, Jumpertz von Schwarzenberg R, et al. ANP system activity predicts variability of fat mass reduction and insulin sensitivity during weight loss. Metabolism 2016;65:935\u201343.","journal-title":"Metabolism"},{"key":"174_CR25","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.2337\/db08-1775","volume":"58","author":"K Mai","year":"2009","unstructured":"Mai K, Andres J, Biedasek K, Weicht J, Bobbert T, Sabath M, et al. Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21. Diabetes 2009;58:1532\u20138.","journal-title":"Diabetes"},{"key":"174_CR26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412\u20139.","journal-title":"Diabetologia"},{"key":"174_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4239\/wjd.v1.i2.36","volume":"1","author":"B Singh","year":"2010","unstructured":"Singh B, Saxena A. Surrogate markers of insulin resistance: a review. World J Diabetes. 2010;1:36\u201347.","journal-title":"World J Diabetes"},{"key":"174_CR28","doi-asserted-by":"publisher","first-page":"E1219","DOI":"10.1210\/jc.2012-1035","volume":"97","author":"F Magkos","year":"2012","unstructured":"Magkos F, Fabbrini E, Conte C, Patterson BW, Klein S. Relationship between adipose tissue lipolytic activity and skeletal muscle insulin resistance in nondiabetic women. J Clin Endocrinol Metab. 2012;97:E1219\u201323.","journal-title":"J Clin Endocrinol Metab"},{"key":"174_CR29","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/ijo.2017.110","volume":"41","author":"KW Ter Horst","year":"2017","unstructured":"Ter Horst KW, van Galen KA, Gilijamse PW, Hartstra AV, de Groot PF, van der Valk FM, et al. Methods for quantifying adipose tissue insulin resistance in overweight\/obese humans. Int J Obes. 2017;41:1288\u201394.","journal-title":"Int J Obes"},{"key":"174_CR30","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42:503\u20138.","journal-title":"Dig Liver Dis"},{"key":"174_CR31","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.2337\/diabetes.51.8.2450","volume":"51","author":"ST Mathews","year":"2002","unstructured":"Mathews ST, Singh GP, Ranalletta M, Cintron VJ, Qiang X, Goustin AS, et al. Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes 2002;51:2450\u20138.","journal-title":"Diabetes"},{"key":"174_CR32","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1089\/1044549041562267","volume":"23","author":"A Zhao","year":"2004","unstructured":"Zhao A, Yu J, Lew JL, Huang L, Wright SD, Cui J. Polyunsaturated fatty acids are FXR ligands and differentially regulate expression of FXR targets. DNA Cell Biol. 2004;23:519\u201326.","journal-title":"DNA Cell Biol"},{"key":"174_CR33","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1042\/BJ20070658","volume":"407","author":"T Murakami","year":"2007","unstructured":"Murakami T, Walczak R, Caron S, Duhem C, Vidal V, Darteil R, et al. The farnesoid X receptor induces fetuin-B gene expression in human hepatocytes. Biochem J. 2007;407:461\u20139.","journal-title":"Biochem J"},{"key":"174_CR34","doi-asserted-by":"publisher","first-page":"632","DOI":"10.2337\/dc15-1876","volume":"39","author":"R Lomonaco","year":"2016","unstructured":"Lomonaco R, Bril F, Portillo-Sanchez P, Ortiz-Lopez C, Orsak B, Biernacki D, et al. Metabolic impact of nonalcoholic steatohepatitis in obese patients with type 2 diabetes. Diabetes Care. 2016;39:632\u20138.","journal-title":"Diabetes Care"},{"key":"174_CR35","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.1210\/jc.2010-0148","volume":"95","author":"JM Brix","year":"2010","unstructured":"Brix JM, Stingl H, H\u00f6llerl F, Schernthaner GH, Kopp HP, Schernthaner G. Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss. J Clin Endocrinol Metab. 2010;95:4877\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"174_CR36","doi-asserted-by":"publisher","first-page":"342","DOI":"10.2337\/dc11-1267","volume":"35","author":"M Bl\u00fcher","year":"2012","unstructured":"Bl\u00fcher M, Rudich A, Kl\u00f6ting N, Golan R, Henkin Y, Rubin E, et al. Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes Care. 2012;35:342\u20139.","journal-title":"Diabetes Care"},{"key":"174_CR37","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1001\/jama.299.10.1139","volume":"299","author":"LP Svetkey","year":"2008","unstructured":"Svetkey LP, Stevens VJ, Brantley PJ, Appel LJ, Hollis JF, Loria CM, et al. Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial. JAMA 2008;299:1139\u201348.","journal-title":"JAMA"},{"key":"174_CR38","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/oby.2010.298","volume":"19","author":"CP Del","year":"2011","unstructured":"Del CP, Bryan DR, Garvey WT, Gower BA, Hunter GR. Dietary adherence during weight loss predicts weight regain. Obesity. 2011;19:1177\u201381.","journal-title":"Obesity"},{"key":"174_CR39","doi-asserted-by":"publisher","first-page":"5421961","DOI":"10.1155\/2018\/5421961","volume":"2018","author":"A Ciresi","year":"2018","unstructured":"Ciresi A, Guarnotta V, Campo D, Giordano C. Hepaticsteatosis index in acromegaly: correlation with insulin resistance regardless of the disease control. Int J Endocrinol. 2018;2018:5421961.","journal-title":"Int J Endocrinol"},{"key":"174_CR40","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3945\/jn.111.150540","volume":"142","author":"D Krupp","year":"2012","unstructured":"Krupp D, Johner SA, Kalhoff H, Buyken AE, Remer T. Long-term dietary potential renal acid load during adolescence is prospectively associated with indices of nonalcoholic fatty liver disease in young women. J Nutr. 2012;142:313\u20139.","journal-title":"J Nutr"},{"key":"174_CR41","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1007\/s00125-013-2995-9","volume":"56","author":"JW Jocken","year":"2013","unstructured":"Jocken JW, Goossens GH, Boon H, Mason RR, Essers Y, Havekes B, et al. Insulin-mediated suppression of lipolysis in adipose tissue and skeletal muscle of obese type 2 diabetic men and men with normal glucose tolerance. Diabetologia 2013;56:2255\u201365.","journal-title":"Diabetologia"},{"key":"174_CR42","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.2337\/db17-0551","volume":"66","author":"JY Kim","year":"2017","unstructured":"Kim JY, Nasr A, Tfayli H, Bacha F, Michaliszyn SF, Arslanian S. Increased lipolysis, diminished adipose tissue insulin sensitivity, and impaired beta-cell function relative to adipose tissue insulin sensitivity in obese youth with impaired glucose tolerance. Diabetes 2017;66:3085\u201390.","journal-title":"Diabetes"},{"key":"174_CR43","first-page":"3740","volume":"85","author":"M Stumvoll","year":"2000","unstructured":"Stumvoll M, Jacob S, Wahl HG, Hauer B, L\u00f6blein K, Grauer P, et al. Suppression of systemic, intramuscular, and subcutaneous adipose tissue lipolysis by insulin in humans. J Clin Endocrinol Metab. 2000;85:3740\u2013\u22125.","journal-title":"J Clin Endocrinol Metab"},{"key":"174_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.soard.2013.07.010","volume":"10","author":"GM Campos","year":"2014","unstructured":"Campos GM, Rabl C, Havel PJ, Rao M, Schwarz JM, Schambelan M, et al. Changes in post-prandial glucose and pancreatic hormones, and steady-state insulin and free fatty acids after gastric bypass surgery. Surg Obes Relat Dis. 2014;10:1\u20138.","journal-title":"Surg Obes Relat Dis"},{"key":"174_CR45","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.metabol.2005.08.018","volume":"55","author":"SB Haugaard","year":"2006","unstructured":"Haugaard SB, Andersen O, Pedersen SB, Dela F, Fenger M, Richelsen B, et al. Tumor necrosis factor alpha is associated with insulin-mediated suppression of free fatty acids and net lipid oxidation in HIV-infected patients with lipodystrophy. Metabolism 2006;55:175\u201382.","journal-title":"Metabolism"},{"key":"174_CR46","doi-asserted-by":"publisher","first-page":"E746","DOI":"10.1152\/ajpendo.00596.2010","volume":"300","author":"TB Curry","year":"2011","unstructured":"Curry TB, Roberts SK, Basu R, Basu A, Schroeder D, Joyner MJ, et al. Gastric bypass surgery is associated with near-normal insulin suppression of lipolysis in nondiabetic individuals. Am J Physiol Endocrinol Metab. 2011;300:E746\u201351.","journal-title":"Am J Physiol Endocrinol Metab"}],"container-title":["Nutrition &amp; Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41387-021-00174-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-021-00174-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-021-00174-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T14:19:40Z","timestamp":1669817980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41387-021-00174-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,5]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["174"],"URL":"https:\/\/doi.org\/10.1038\/s41387-021-00174-z","relation":{},"ISSN":["2044-4052"],"issn-type":[{"value":"2044-4052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,5]]},"assertion":[{"value":"19 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocols were approved by the Institutional Review Board of the Charit\u00e9 Medical School (EA1\/140\/12). All methods were performed in accordance with the relevant guidelines and regulations. Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All subjects gave written informed consent prior to their inclusion in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The work described has not been published before. It is not under consideration for publication anywhere else. This manuscript has been approved by all co-authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"31"}}